MECOJ publishes original research, reviews, and case reports that improve the understanding, prevention, diagnosis, and treatment of cancer. The journal welcomes clinical studies, real-world evidence, epidemiology, translational and molecular research, and research on supportive and palliative care. It is particularly interested in studies that reflect the populations, health systems, and cancer burden of the Middle East and other under-represented regions, while also welcoming research of global relevance.
The "Middle Eastern Cancer and Oncology Journal (MECOJ)" invites a broad range of contributions across various domains of oncology. The topics include, but are not limited to:
- Tumor Biology and Mechanisms: Deep dives into the cellular and molecular underpinnings of tumors, including their initiation, growth, spread, and the mechanisms of immune system evasion.
- Clinical Trials and Therapeutics: Reports on the design, methodology, implementation, and results of clinical trials; critical evaluations of new and existing therapeutic protocols.
- Genomic and Molecular Oncology: Cutting-edge research on genetic mutations, molecular pathways, and biomarker developments that support personalized medicine in cancer treatment.
- Innovative Treatment Strategies: Exploration of new treatment modalities including immunotherapy, targeted therapy, and advanced radiation techniques, and their clinical outcomes.
- Epidemiology and Public Health: Investigations into the epidemiological aspects of cancer, including incidence and prevalence, with an emphasis on identifying risk factors and preventive strategies influenced by regional health policies.
- Quality of Life and Palliative Care: Research focused on improving the well-being of cancer patients, encompassing advanced palliative care methods and psychosocial interventions.
- Innovative Diagnostic Technologies: Development and validation of diagnostic tools that improve early detection and diagnosis of cancer, including novel imaging technologies and molecular diagnostics.
- Assessment Tools in Oncology: Development, validation, and application of methodological instruments that assess treatment outcomes, patient satisfaction, or quality of life, providing critical insights into the efficacy of oncological interventions.
- Climate Change and Cancer: Studies on how environmental changes, particularly those driven by climate change, are impacting cancer incidence, progression, and the geographical distribution of cancer types, along with adaptations required in clinical practice to address these challenges.
- Complementary and Alternative Medicine (CAM): Explorations of non-traditional therapies and their role in cancer prevention, treatment, and survivorship care. Contributions may include studies on herbal medicines, nutritional therapies, acupuncture, and other integrative treatment approaches that have potential to complement conventional oncology practices.
